awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38946563-C9CA60EC-E346-4EBF-8C5C-13CA0BF11F22
Q38946563-C9CA60EC-E346-4EBF-8C5C-13CA0BF11F22
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38946563-C9CA60EC-E346-4EBF-8C5C-13CA0BF11F22
Evaluation of the immunogenicity of the dabigatran reversal agent idarucizumab during Phase I studies.
P2093
Q38946563-C9CA60EC-E346-4EBF-8C5C-13CA0BF11F22
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38946563-C9CA60EC-E346-4EBF-8C5C-13CA0BF11F22
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
23f52f97b67626134dade91f9fcf61161a05e2b6
P1545
10
http://www.w3.org/2001/XMLSchema#string
P2093
Joachim Stangier
http://www.w3.org/2001/XMLSchema#string